Latest News
The puzzle pieces are falling into place for subpar stock market returns.
Via The Motley Fool · September 20, 2026
Ackman quickly deployed the capital raised in his new $5 billion fund.
Via The Motley Fool · September 20, 2026
TSMC owns more than two-thirds of the chip foundry market.
Via The Motley Fool · September 20, 2026
Dubai has become a prominent destination for people looking to purchase property, establish a home, or explore real estate investment opportunities. The ci
Via Talk Markets · September 20, 2026
The September Effect can sink stocks, but likely not these three.
Via The Motley Fool · September 20, 2026
Investors are staring at a market triple-whammy.
Via The Motley Fool · September 20, 2026
Retaining some sort of fresh setting is significant with households, locations, professional medical establishments, educational institutions, eateries, in
Via Talk Markets · September 20, 2026
Sanofi (NASDAQ:SNY) is prioritizing continued growth in Specialty Care while preparing for the loss of exclusivity of Dupixent in the early part of the next decade, according to Manuela Buxo, the company’s executive vice president and head of Specialty Care.
Speaking at a Morgan Stanley fireside ch
Via MarketBeat · September 20, 2026

Cho Thuê Máy Photocopy Màu Tiết Kiệm Chi Phí NhấtNhiều văn phòng bỏ ra 80-150 triệu đồng mua máy photocopy màu mới, rồi sau 18 tháng nhận ra nhu cầu in đã
Via Talk Markets · September 20, 2026
Tech stocks could be a greater risk than some investors realize.
Via The Motley Fool · September 20, 2026
Dogs and cats take company, convenience, along with delight straight into each of our existence. No matter whether anyone talk about your own home which ha
Via Talk Markets · September 20, 2026
A new well-designed bathing room can be over simply a well-designed place. It can be a crucial portion of everyday activities wherever convenience, persona
Via Talk Markets · September 20, 2026
While many seniors are hoping for a large cost-of-living adjustment (COLA), they won't actually be getting a raise in the traditional sense.
Via The Motley Fool · September 20, 2026
The title is moving to his son. The $365 billion isn't.
Via The Motley Fool · September 20, 2026
Current lifetime typically is included with far more stuff in comparison with readily available living space. No matter if that you are going into a comple
Via Talk Markets · September 20, 2026
Bloom Energy is seeing massive earnings growth, while Plug Power is working to clean up its finances.
Via The Motley Fool · September 20, 2026
The market might seem bloated, but these stocks still have a long runway for growth.
Via The Motley Fool · September 20, 2026
Pacific Biosciences of California (NASDAQ:PACB) is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve sequencing economics, Chief Executive Officer Mark Van Oene said during a Morgan Stanley discussion.
Via MarketBeat · September 20, 2026
Shipment has grown to be a crucial component of current small business, in particular seeing that on the net looking, overseas deal, in addition to direct-
Via Talk Markets · September 20, 2026
MPLX LP didn't just team up with a pipeline rival; it also teamed up with two rivals in the upstream sector, too.
Via The Motley Fool · September 20, 2026
Centene (NYSE:CNC) reaffirmed its 2026 adjusted diluted earnings-per-share guidance of more than $4.80 at the Deutsche Bank Healthcare Summit, with Chief Executive Officer Sarah London saying the company’s performance through the first two months of the third quarter was in line with expectations.
Via MarketBeat · September 20, 2026
Royal Bank Of Canada (NYSE:RY) Chief Financial Officer Katherine Gibson said the bank has made progress toward the strategic and financial objectives outlined at its Investor Day, citing growth across Canadian and global businesses, improved profitability and cost discipline.
Speaking at a Barclays
Via MarketBeat · September 20, 2026
Tesla has grown at a torrential rate in the past, but it has slowed down recently.
Via The Motley Fool · September 19, 2026
One designs chips; the other manufactures them, and their valuations tell starkly different stories about growth versus value.
Via The Motley Fool · September 19, 2026
Rockwell Automation (NYSE:ROK) executives said customer sentiment remains broadly positive despite inflation, tariffs and trade-policy uncertainty, with manufacturers continuing to prioritize productivity, modernization and automation investments.
Speaking at Morgan Stanley’s 14th Annual Laguna Con
Via MarketBeat · September 19, 2026
Troim purchased shares indirectly through Drew Trust at $4.38 each, signaling confidence in the offshore drilling company following a strong 43% one-year return.
Via The Motley Fool · September 19, 2026
Life insurers generally benefit from higher rates, but there are some negatives to consider.
Via The Motley Fool · September 19, 2026
The provider of a software development lifecycle platform reported a notable insider disposition after its stock price soared.
Via The Motley Fool · September 19, 2026
Turn Your Earpiece Time Into Actual CashMobile phones have evolved far beyond simple communication gimmick or tool for social sensitive scrolling. Today, s
Via Talk Markets · September 19, 2026
Incyte (NASDAQ:INCY) executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after 2029.
Chief Executive Officer Bill Meury said the company’s pipeline has changed substantially over t
Via MarketBeat · September 19, 2026
The $72,000 ending is the easy part. Collecting it involved an 83% loss and a 15-year wait just to get back to even.
Via The Motley Fool · September 19, 2026
Nvidia's 55.6% net margin dwarfs Applied Materials' 24.7%, but one trades at a steep valuation premium while the other faces customer concentration risk.
Via The Motley Fool · September 19, 2026
Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined its strategy for advancing zilebesiran, an investigational RNA interference, or RNAi, therapy designed to provide sustained blood-pressure control with twice-yearly dosing for people with uncontrolled hypertension and elevated cardiovascular risk.
Duri
Via MarketBeat · September 19, 2026
The Federal Open Market Committee (FOMC) just raised interest rates for the first time in three years.
Via The Motley Fool · September 19, 2026
The language learning platform provider reported a notable insider sale as its stock plunged 47% over the past year.
Via The Motley Fool · September 19, 2026
After the sale, West still held $6.1 million in stock.
Via The Motley Fool · September 19, 2026
Oracle's AI spending spree needs power and cooling to match. Two industrial stocks are already cashing in on that demand.
Via The Motley Fool · September 19, 2026
IAMGold (TSX:IMG) stock looks way too cheap to ignore despite euphoric five-year gains in the books.
Via The Motley Fool · September 19, 2026
Brookfield Asset Management (NYSE:BAM) used its 2026 Investor Day to outline plans to double fee-bearing capital by 2031, supported by fundraising across flagship funds, complementary strategies, insurance capital and private wealth products. Management also emphasized the July acquisition of the re
Via MarketBeat · September 19, 2026
These Canadian stocks offer strong growth potential, with a few pulling back from their highs and now presenting attractive entry points.
Via The Motley Fool · September 19, 2026
Turn Your Phone Time Into Real CashMobile earpiece experience evolved far beyond simple communication devices or tools for social media scrolling. Today, s
Via Talk Markets · September 19, 2026
Uncover the best performing gold stocks from the 2026 TSX30. Find out which gold mining companies have shown impressive returns.
Via The Motley Fool · September 19, 2026
Following a brutal 2026, the five-year case comes down to reaccelerating software growth and a 31-year dividend streak.
Via The Motley Fool · September 19, 2026
Comparing this relatively small part of Berkshire's business to its publicly traded counterparts illustrates just how enormous the conglomerate has become.
Via The Motley Fool · September 19, 2026
Definium Therapeutics (NASDAQ:DFTX) reported positive top-line results from Panorama, its second Phase III study of DT120 ODT 100 mcgs in generalized anxiety disorder, or GAD. The company said the single-dose treatment met its primary endpoint and all key secondary endpoints, adding to positive pivo
Via MarketBeat · September 19, 2026
The defense industry environment is changing, and it's putting pressure on traditional ways of doing business.
Via The Motley Fool · September 19, 2026
One fuel cell stock is chasing AI power demand with billions in backing. Another is staying out of the race entirely.
Via The Motley Fool · September 19, 2026
Buying a home is a major financial decision, and choosing the right mortgage can affect both upfront expenses and long-term housing costs. For eligible vet
Via Talk Markets · September 19, 2026
The risk of a sudden reversal in AI growth looms large over Oracle stock.
Via The Motley Fool · September 19, 2026

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period.
Speaking at the Morgan Stanley Global Healthcare Confere
Via MarketBeat · September 19, 2026